Carl Soltau
Carl is a medicinal chemist focused on developing novel therapeutic strategies and understanding the mechanisms required to address major challenges in preserving human health. His research has centred on the design and synthesis of nitroxide-based hybrid molecules with multiple modes of action, including anti-inflammatory, and anticancer activity.
His research is driven by a broader goal of uncovering how molecular design can be leveraged to better understand and overcome complex disease processes.
Abstracts this author is presenting:
